Humanigen, Inc.

Published: May 9, 2018, 5:40 p.m.

b'

Humanigen, Inc. (OTCQB:\\xa0HGEN) is a biopharmaceutical company pursuing cutting-edge science to develop our proprietary monoclonal antibodies for immunotherapy and oncology treatments. Joining our podcast today is Cameron Durrant, Chairman and CEO.\\xa0

'